26 June, 2017
The quarterly performance stats for ASML Holding N.V. stands at 1.72% and the half-yearly performance is at 20.94%. (QSII) has declined 1.28% since June 22, 2016 and is downtrending. It has underperformed by 16.70% the S&P500. J P Morgan Chase & Co set a €140.00 ($155.56) price objective on shares of ASML Holding and gave the stock a buy rating in a research note on Wednesday.
ASML Holding N.V. reported a price of 128.49 today, indicating a change of -2.25%. The stock has "Sector Perform" rating by RBC Capital Markets on Thursday, March 17. The rating was upgraded by Bryan Garnier & Cie to "Buy" on Thursday, January 21. UBS downgraded ASML Holding NV (ADR) (NASDAQ:ASML) on Thursday, July 21 to "Neutral" rating. On Tuesday, April 19 the stock rating was maintained by Summit Research with "Hold". The stock has "Add" rating by SNS Securities on Tuesday, July 21.
About 28,223 shares traded. Deutsche Bank upgraded ASML Holding NV (ADR) (NASDAQ:ASML) on Friday, January 22 to "Hold" rating. It has outperformed by 27.82% the S&P500.
The net profit margin for ASML Holding N.V. stands at 23.30%. The company has market cap of $57.90 billion. The Company is a manufacturer of chip-making equipment.
ASML Holding N.V.'s P/E stands at 28.65, while the P/S is at 6.78 and earnings per share this year of 7.30%. The Company is engaged in the development, production, marketing, selling and servicing of semiconductor equipment systems, consisting of lithography systems.
Equity Commonwealth is an internally managed and self-advised real estate investment trust.
Quality Systems, Inc. primarily, through its NextGen Healthcare subsidiary, provides technology solutions and services to the ambulatory care market in the United States. The Firm conducts its activities primarily through EQC Operating Trust. The company presently has a consensus rating of "Buy" and an average price target of $125.00. Therefore 33% are positive. For the next year, analysts anticipate that the firm will report sales of $10.19 billion per share, with estimates ranging from $9.73 billion to $10.65 billion. The stock has "Neutral" rating by Citigroup on Monday, September 14. The stock has "Neutral" rating by Bank of America on Wednesday, August 17.